喘和睡眠呼吸障碍在小儿腺切除试验中用于打研究研究
Po-Yang Tsou1, Seyni Gueye-Ndiaye2, Krysta Lynn Gorman3
1Division of Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.
Sleep & breathing = Schlaf & Atmung
|December 5, 2024
概括
在患有轻度睡眠呼吸障碍 (SDB) 的儿童中,中度至重度的喘与更差的生活质量和增加SDB症状有关. 对于这些相互关联的条件,建议采用联合管理策略.
科学领域:
- 儿科肺病学 儿科肺病学
- 睡眠的药物 睡眠的药物
- 过敏和免疫学的过敏和免疫学.
背景情况:
- 喘经常在患有睡眠呼吸障碍 (SDB) 的儿童中观察到.
- 儿童喘和SDB相关结果之间的确切关系需要进一步阐明.
- 儿童腺切除治疗打 (PATS) 研究为研究这些关联提供了一个队列.
研究的目的:
- 在被诊断为轻度SDB (mSDB) 的儿童中识别喘的危险因素.
- 评估喘与各种睡眠相关结果的严重程度之间的关联.
- 为了在mSDB队列中比较轻度喘儿童和中度至重度喘儿童之间的结果.
主要方法:
- 对425名患有mSDB.的3-12岁至9岁儿童进行横截面分析.
- 评估与睡眠相关的结果,包括SDB症状 (PSQ-SRBD),生活质量 (OSA-18),嗜睡和多睡眠/多动图测量.
- 根据护理人员报告或综合性喘严重性指数 (CASI) 评分 ≥4定义的喘,分类为轻度 (CASI <4) 或中度至重度 (CASI ≥4).
主要成果:
- 喘患病率为19.1% (12.0%轻度,7.1%中度至重度).
- 环境烟草烟雾暴露和阿托皮标志物与喘有关.
- 中度至重度喘与增加的SDB症状 (PSQ-SRBD),降低生活质量 (OSA-18) 和更高的兴奋指数相关.
结论:
- 中度至重度的喘显著恶化了生活质量,并加剧了mSDB儿童的SDB症状.
- 共同的风险因素和重叠的症状突出了喘和mSDB的相互联系.
- 协调的预防和管理策略对于同时解决这两种情况至关重要.
相关概念视频
Sleep Apnea
128
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
128
Tonsillitis I: Introduction
207
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Etiology
Three primary contributing factors have been identified.
207
Other Pulmonary Disorders
804
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
804
Chronic Pharyngitis
1.1K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.1K
Antiasthma Drugs: β2-Adrenoceptor Agonists
233
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
233
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
232
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
232


